...J.H. Brown; B.G. Murphy; A.F. Douglas; C.D. Short; D. Bhatnagar; M.I. Mackness; L.P. Hunt; C.C. Doherty; P.N. Durrington Coronary heart disease (CHD) is more common in patients with chronic renal failure and is a major cause of death after renal transplantation. Elevated serum levels of lipoprotein...

...E. Hernández; M. Prag; C. Alamo; A. Araque; J.M. Morales; J.M. Alcazar; L.M. Ruilope; J.L. Rodicio Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic and cardiovascular complications in the general population and in hemodialysis patients. Increased Lp(a) levels have been also...

...Olof Heimbürger; Peter Stenvinkel; Lars Berglund; Anders Tranæus; Bengt Lindholm Markedly increased plasma lipoprotein(a) [Lp(a)] levels have recently been reported in continuous ambulatory peritoneal dialysis (CAPD) patients but the genesis is obscure. Lp(a) levels in CAPD are in general higher...

... and contribute to disease progression. Among such alterations, increased levels of lipoprotein(a) [Lp(a)] are common and may be related, in part, to the degree of proteinuria. Omega-3 polyunsaturated fatty acids (ω-3 FA) have been reported to decrease Lp(a) concentrations in nonrenal subjects. In addition...

...Sae Yong Hong; Dong Ho Yang Recently there has been a renewed interest in the possibility that lipoprotein(a) -Lp(a) – may be important in the pathogenesis of thrombosis-related disease. In nephrotic syndrome, hyperlipidemia is a common finding, and thrombosis is a major complication...

...Yukihiko Kawasaki; Junzo Suzuki; Ruriko Nozawa; Shigeo Suzuki; Hitoshi Suzuki Aim: To clarify whether plasma lipoproteins, including Lp(a), can predict relapse pattern in the first years after diagnosis of nephrotic syndrome (NS), we evaluated them in patients with steroid-sensitive NS. Methods: We...

..., but no other abnormalities such as splenomegaly, renal swelling and venous thrombus were found. At this time, we suspected that this nephrotic syndrome was due to primary renal disease. With regard to lipogenesis, serum lipoprotein(a) [Lp(a)] has a thrombogenic effect in the nephrotic state, as has been...

... (AT), immunoglobulin (Ig) M and G (by nephelometry), antigens of endothelial von Willebrand factor (vWF), type 1 plasminogen activator inhibitor and thrombomodulin, interleukin-6, lipoprotein(a) [Lp(a)] and EPO (by ELISA), and albumin, fibrinogen, iron metabolism indices, thyroid-stimulating hormone, phosphorus...

...Eduard A. Iliescu; Santica M. Marcovina; Alexander R. Morton; Marlys L. Koschinsky This cross-sectional study was undertaken to examine the relationship between plasma lipoprotein(a) [Lp(a)] level and peritoneal dialysis (PD) albumin clearance while controlling for the influence...

...Wolfgang Herrmann; Sabine Quast; Astrid Ellgass; Kai Wolter; Stefan T. Kiessig; Ewald Molinari; Werner Riegel Lipoprotein(a) [Lp(a)] excess combined with hyperhomocysteinaemia and hyperfibrinogenaemia may contribute to the high incidence of vascular diseases in dialysis patients. This study...

...Cristina Hernández; Pilar Chacón; Ramón Martí; Luis García-Pascual; Jordi Mesa; Rafael Simó Background/Aim: The possible association between lipoprotein(a) [Lp(a)] and albumin excretion rate (AER) is a topic that has generated conflicting views. The aim of this study was to determine...

...Mari Tanaka; Hisako Yanagi; Ryoichi Ando; Satoshi Kurihara; Chiaki Hirano; Kimiko Kobayashi; Shuichi Kikuchi; Hideo Hamaguchi; Shigeru Tsuchiya; Shigeo Tomura The elevation of serum or plasma lipoprotein(a) [Lp(a)] levels is regarded as an independent risk factor for cardiovascular disease...